|
Diaz-Carrasco MS, Sanchez-Salinas A, Fernandez-Avila JJ, Olmos-Jimenez R, Espanol-Morales I, Espuny-Miro A. Prospective observational study of oral clonazepam to prevent high-dose busulfan-induced seizures in adult patients. J Egypt Natl Canc Inst. 2025 Feb 3;37(1):4. doi: 10.1186/s43046-025-00257-3. PubMed PMID: 39894848.
AÑO: 2025
|
39894848
|
Oliver-Caldes A, Espanol-Rego M, Zabaleta A, Gonzalez-Calle V, Navarro-Velazquez S, Inoges S, de Cerio AL, Cabanas V, Lopez-Munoz N, Rodriguez-Otero P, Reguera JL, Moreno DF, Martinez-Cibrian N, Lopez-Corral L, Perez-Amill L, Martin-Antonio B, Rosinol L, Cid J, Tovar N, Saez-Penataro J, Lopez-Parra M, Olesti E, Guillen E, Varea S, Rodriguez-Lobato LG, Battram AM, Gonzalez MS, Sanchez-Salinas A, Gonzalez-Navarro A, Ortiz-Maldonado V, Delgado J, Prosper F, Juan M, Martinez-Lopez J, Moraleda JM, Mateos MV, Urbano-Ispizua A, Paiva B, Pascal M, Fernandez de Larrea C. Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma. Clin Cancer Res. 2024 May 15;30(10):2085-2096. doi: 10.1158/1078-0432.CCR-23-3759. PubMed PMID: 38466644.
AÑO: 2024; IF: 10.0
|
|
Poveda-Garcia A, Ruiz E, Moreno MJ, Espanol I, Sanchez-Salinas A, Garcia-Hernandez AM, Blanquer M, Martinez I, Sanchez-Villalobos M, Garcia Garay MC, Salido E, Heredia A, Navarro-Almenzar B, Monserrat J, Sanchez-Salas JA, Martinez-Mellado AJ, Minguela A, Campillo JA, Lopez-Hernandez R, Galian JA, Moraleda JM, Roldan V, Cabanas V. Real-world outcomes of tandem ASCT in newly diagnosed multiple myeloma patients with standard risk features: a single-center analysis. Bone Marrow Transplant. 2024 Nov;59(11):1625-1627. doi: 10.1038/s41409-024-02404-1. Epub 2024 Aug 26. No abstract available. PubMed PMID: 39187602.
AÑO: 2024; IF: 4.5
|
|
Pinana JL, Martino R, Vazquez L, Lopez-Corral L, Perez A, Chorao P, Avendano-Pita A, Pascual MJ, Sanchez-Salinas A, Sanz-Linares G, Olave MT, Arroyo I, Tormo M, Villalon L, Conesa-Garcia V, Gago B, Terol MJ, Villalba M, Garcia-Gutierrez V, Cabero A, Hernandez-Rivas JA, Ferrer E, Garcia-Cadenas I, Teruel A, Navarro D, Cedillo A, Sureda A, Solano C; Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination. Bone Marrow Transplant. 2023 May;58(5):567-580. doi: 10.1038/s41409-023-01946-0. Epub 2023 Feb 28. PubMed PMID: 36854892; PubMed Central PMCID: PMC9974060.
AÑO: 2023; IF: 4.5
|
|
Pinana JL, Vazquez L, Calabuig M, Lopez-Corral L, Martin-Martin G, Villalon L, Sanz-Linares G, Conesa-Garcia V, Sanchez-Salinas A, Gago B, Facal A, Risco-Galvez I, Olave MT, Espigado I, Lopez-Jimenez J, Hernandez-Rivas JA, Avendano-Pita A, Arroyo I, Ferrer E, Garcia-Cadenas I, Gonzalez-Santillana C, Roldan-Perez A, Ferrer B, Guerreiro M, Suarez-Lledo M, Camara A, Campos-Beltran D, Navarro D, Cedillo A, Sureda A, Solano C; Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC); Martino R. One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients. Blood Cancer J. 2023 Jan 5;13(1):8. doi: 10.1038/s41408-022-00778-3. PubMed PMID: 36599843; PubMed Central PMCID: PMC9812742.
AÑO: 2023; IF: 12.9
|